Cogent Biosciences Inc (COGT)

Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Research and Development	2.81% 48.72	50.13	38.87	36.04	36.74
Costs And Expenses	2.27% 58.23	59.58	47.09	43.24	43.74
Depreciation and Amortization	2.93% 0.598	0.581	0.562	0.529	0.42
Operating Income/Loss	2.27% -58.23	-59.58	-47.09	-43.24	-43.74
Nonoperating Income/Loss	7.98% 3.863	4.198	3.009	4.65	4.127
Income/Loss From Continuing Operations Before Tax	8.75% -54.37	-59.58	-44.08	-38.59	-39.62
Income/Loss From Continuing Operations After Tax	1.84% -54.37	-55.38	-44.08	-38.59	-39.62
Net Income/Loss	1.84% -54.37	-55.38	-44.08	-38.59	-39.62
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	97.23% 2.3834	86.17	74.75	70.73	3.9597
Diluted Average Shares	97.23% 2.3834	86.17	74.75	70.73	3.9597
Basic Earnings Per Share	1.56% -0.63	-0.64	-0.59	-0.55	-0.55
Diluted Earnings Per Share	1.56% -0.63	-0.64	-0.59	-0.55	-0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-